$12.37
-0.11[-0.88%]
At close: Apr 26
$12.37
0[0.00%]
After Hours: 4:20PM EDT
Enanta Pharma
(NASDAQ:ENTA)Enanta Pharma Stock (NASDAQ:ENTA), Insider Trading Activity
Enanta Pharma: Insider buying and selling updated today.
Insider Shares Owned
1.543M
Insider Percentage Owned
7.30%
Institutional Shares Held
6.551M
Institutional Percentage Held
31.0%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Terry Vance | DIRECTOR | -15.295K | $9.12 | -$139.49K | SELL | -72.51% | 5.8K | Dec 13 | View |
| Dec 06, 2023 | Brendan Luu | SR. VP, BUSINESS DEV. | -2.125K | $9.63 | -$20.46K | SELL | -5.47% | 36.736K | Dec 05 | View |
| Dec 06, 2023 | Lynn Tara Kieffer | SR. VP, NEW PROD. STRAT. & DEV | -2.125K | $9.63 | -$20.46K | SELL | -5.40% | 37.26K | Dec 05 | View |
| Dec 06, 2023 | Nathaniel S Gardiner | SR. VP & GENERAL COUNSEL | -2.412K | $9.63 | -$23.23K | SELL | -2.26% | 104.08K | Dec 05 | View |
| Dec 06, 2023 | Scott Rottinghaus | SR. VP & CMO | -534 | $9.63 | -$5.14K | SELL | -1.98% | 26.466K | Dec 05 | View |
| Dec 06, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP, R&D & CSO | -2.412K | $9.63 | -$23.23K | SELL | -0.65% | 370.695K | Dec 05 | View |
| Dec 06, 2023 | PAUL MELLETT | SR. VP, FINANCE & ADMIN. & CFO | -2.412K | $9.63 | -$23.23K | SELL | -2.51% | 93.549K | Dec 05 | View |
| Dec 06, 2023 | Jay Luly | PRESIDENT AND CEO | -7.23K | $9.63 | -$69.62K | SELL | -0.89% | 806.793K | Dec 05 | View |
| Mar 17, 2023 | PAUL MELLETT | TREASURER AND CFO | 0 | $29.21 | -$317.64K | SELL-OPTIONS | 0.00% | 97.556K | Mar 15 | View |
| Mar 17, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP & CSO | 0 | $29.22 | -$424.01K | SELL-OPTIONS | 0.00% | 374.702K | Mar 15 | View |
| Mar 14, 2023 | Jay Luly | PRESIDENT AND CEO | 0 | $29.58 | -$869.86K | SELL-OPTIONS | 0.00% | 819.81K | Mar 13 | View |
| Feb 13, 2023 | PAUL MELLETT | TREASURER AND CFO | -5K | $53.76 | -$268.82K | SELL | -5.65% | 83.463K | Feb 09 | View |
| Dec 16, 2022 | Jay Luly | PRESIDENT AND CEO | 0 | $29.41 | -$918.81K | SELL-OPTIONS | 0.00% | 773.805K | Dec 16 | View |
| Apr 05, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0 | $56.12 | -$2.58M | SELL-OPTIONS | 0.00% | 34.982K | Apr 01 - Apr 04 | View |
| Mar 22, 2022 | BRUCE CARTER | DIRECTOR | 0 | $46.70 | -$253.49K | SELL-OPTIONS | 0.00% | 0 | Mar 21 | View |
| Mar 03, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0 | $56.83 | -$984.48K | SELL-OPTIONS | 0.00% | 34.982K | Mar 01 - Mar 02 | View |
| Jan 13, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0 | $55.00 | -$379.24K | SELL-OPTIONS | 0.00% | 32.902K | Jan 11 | View |
| Dec 03, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | -842 | $65.84 | -$629.66K | SELL | -2.50% | 32.902K | Dec 01 | View |
| Nov 02, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0 | $66.70 | -$347.20K | SELL-OPTIONS | 0.00% | 26.944K | Nov 01 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.